Denosumab Discontinuation in Patients Treated for Low Bone Density and Osteoporosis

被引：15
|
作者：
Zeytinoglu, Meltem [1 ]
Naaman, Sandra C. [2 ]
Dickens, Laura T. [1 ]
机构：
[1] Univ Chicago, Sect Adult & Pediat Endocrinol Diabet & Metab, Dept Med, 5841 South Maryland Ave,AMB M267, Chicago, IL 60637 USA
[2] Univ Chicago, Dept Med, Sect Gen Internal Med, 355 East Grand St, Chicago, IL 60611 USA
来源：
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA | 2021年 / 50卷 / 02期
关键词：
Denosumab; Osteoporosis treatment; Antiresorptive therapy; Bone disorders; Sequential therapy; Fracture; SPONTANEOUS VERTEBRAL FRACTURES; POSTMENOPAUSAL WOMEN; ZOLEDRONIC ACID; MINERAL DENSITY; EXPOSURE; RISEDRONATE; EXTENSION; THERAPY; TRIAL; TERIPARATIDE;
D O I：
10.1016/j.ecl.2021.03.004
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：205 / 222
页数：18
相关论文
共 50 条
  • [1] EFFICACY OF DENOSUMAB ON BONE MINERAL DENSITY IN PATIENTS WITH POSTMENOPAUSAL OSTEOPOROSIS
    Tsagareli, M.
    Giorgadze, E.
    Dolidze, N.
    Sulikashvili, T.
    Jeiranashvili, N.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S252 - S252
  • [2] Risk factors for denosumab discontinuation in patients with postmenopausal osteoporosis
    Hattori, Kyosuke
    Takahashi, Nobunori
    Kojima, Toshihisa
    Imagama, Shiro
    MODERN RHEUMATOLOGY, 2023, 33 (04) : 843 - 850
  • [3] PATIENTS' CHARACTERISTICS RELATED TO BONE MINERAL DENSITY EVOLUTION AT DENOSUMAB DISCONTINUATION: THE REOLAUS BONE PROJECT
    Liebich, G.
    Rodriguez, E. Gonzalez
    Lamy, O.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S375 - S376
  • [4] Impact of denosumab discontinuation on changes in bone mineral density and bone erosion in rheumatoid arthritis patients
    Tanaka, Sakae
    Kobayashi, Makiko
    Saito, Kengo
    Takita, Atsushi
    MODERN RHEUMATOLOGY, 2022, 32 (02) : 284 - 291
  • [5] Efficacy and Safety of Denosumab in Osteoporosis or Low Bone Mineral Density Postmenopausal Women
    Chen, Yi
    Zhu, Jun
    Zhou, Yiqin
    Peng, Jinhui
    Wang, Bo
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [6] Bone Mineral Density Changes After 1 Year of Denosumab Discontinuation in Postmenopausal Women with Long-Term Denosumab Treatment for Osteoporosis
    Popp, Albrecht Werner
    Varathan, Nadshathra
    Buffat, Helene
    Senn, Christoph
    Perrelet, Romain
    Lippuner, Kurt
    CALCIFIED TISSUE INTERNATIONAL, 2018, 103 (01) : 50 - 54
  • [7] Bone Mineral Density Changes After 1 Year of Denosumab Discontinuation in Postmenopausal Women with Long-Term Denosumab Treatment for Osteoporosis
    Albrecht Werner Popp
    Nadshathra Varathan
    Helene Buffat
    Christoph Senn
    Romain Perrelet
    Kurt Lippuner
    Calcified Tissue International, 2018, 103 : 50 - 54
  • [8] DENOSUMAB TREATMENT IMPROVES CORTICAL MASS AND DENSITY IN POSTMENOPAUSAL PATIENTS TREATED FOR OSTEOPOROSIS
    Cirstoiu, C.
    Cirstoiu, M.
    Secara, D.
    Munteanu, O.
    Bodean, O.
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 : S618 - S618
  • [9] Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass
    Bone, Henry G.
    Bolognese, Michael A.
    Yuen, Chui Kin
    Kendler, David L.
    Miller, Paul D.
    Yang, Yu-Ching
    Grazette, Luanda
    San Martin, Javier
    Gallagher, J. Christopher
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (04): : 972 - 980
  • [10] Denosumab and the Risk of Diabetes in Patients Treated for Osteoporosis
    Huang, Huei-Kai
    Chuang, Albert Tzu-Ming
    Liao, Tzu-Chi
    Shao, Shih-Chieh
    Liu, Peter Pin-Sung
    Tu, Yu-Kang
    Lai, Edward Chia-Cheng
    JAMA NETWORK OPEN, 2024, 7 (02) : E2354734
12345